Skip to main content

CORRECTION article

Front. Immunol., 21 August 2023
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Corrigendum: Characteristics of cardiac involvement in immune-mediated necrotizing myopathy

Mengyang LiuMengyang Liu1Ying LinYing Lin1Lingya Qiao,Lingya Qiao1,2Juan ChenJuan Chen1Qiang Shi*Qiang Shi1*
  • 1Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, China
  • 2School of Medicine, Nankai University, Tianjin, China

A Corrigendum on
Characteristics of cardiac involvement in immune-mediated necrotizing myopathy

By Liu M, Lin Y, Qiao L, Chen J and Shi Q (2023). Front. Immunol. 14:1094611. doi: 10.3389/fimmu.2023.1094611

In the published article, there was an error in the Funding statement. The original funded project “the National Natural Science Foundation of China (No.81771358)” was mistaken as an ongoing project. Currently the former funded project “the National Natural Science Foundation of China (No.81771358)” had been concluded and should not have appeared in the Funding section. The correct Funding statement appears below.

Funding

This work was supported by the military training injury prevention research mission (No.21XLS28).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: immune-mediated necrotizing myopathy (IMNM), cardiac involvement, anti-SRP antibody, anti-HMGCR antibody, muscle biopsy

Citation: Liu M, Lin Y, Qiao L, Chen J and Shi Q (2023) Corrigendum: Characteristics of cardiac involvement in immune-mediated necrotizing myopathy. Front. Immunol. 14:1233453. doi: 10.3389/fimmu.2023.1233453

Received: 02 June 2023; Accepted: 15 August 2023;
Published: 21 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Liu, Lin, Qiao, Chen and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qiang Shi, shiq301@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.